TelyRx Holdings Inc. has seen notable price movements amid recent developments.
This week, TelyRx Holdings Inc. (TELY.TO) experienced a daily increase of 5.66%, though it remains down 3.45% over the week. As the company completes its qualifying transaction and expands its operations, investors are watching closely for further developments.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$70.43M
52W high
$4.25
52W low
$2.00
1W change
-3.45%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 114.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+114.3% Upside
Current Price
C$2.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
95.4%
Annualized
90-Day Vol
97.1%
Annualized
Trend (90d)
-42.7%
Annualized drift
90d Mean
C$2.40
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.66 | C$1.91 โ C$3.70 |
| 60 trading days | C$2.53 | C$1.59 โ C$4.03 |
| 90 trading days | C$2.40 | C$1.36 โ C$4.25 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: While TelyRx has shown some positive price action recently, its overall year-to-date performance remains negative. Investors should consider the company's operational expansions and financial results as they evaluate the stock's potential.
C$2.83 Closing Price with 5.66% Daily Gain
TelyRx's stock closed at C$2.83, reflecting a notable daily increase, yet it remains under pressure from its year-to-date performance.
Bull case
The company's recent financial results show strong revenue growth, with a reported 35% increase in Q1 2026. This upward trend may attract investor interest, especially since analysts have a bullish outlook, with an average price target significantly above the current trading price.
Bear case
Despite the recent gains, TelyRx's year-to-date decline of 20% and negative profit margins raise concerns. Additionally, the low trading volume compared to the average could indicate a lack of investor confidence.
Price Action Overview
TelyRx Holdings Inc. (TELY.TO) has seen a daily price increase of 5.66%, closing at C$2.83. However, the stock has experienced a decline of 3.45% over the past week and remains down 20.00% year-to-date. Investors are observing the stock closely as it navigates these fluctuations.
Recent Company Developments
TelyRx recently completed its qualifying transaction, rebranding from Apolo V Acquisition Corp. This strategic move aims to enhance its operational capabilities and visibility in the market. Additionally, the company announced a significant expansion of its Clearwater, Florida operations, tripling its footprint to meet rising demand for digital healthcare solutions.
Technical Picture
Currently, TelyRx trades above its 50-day moving average of C$2.63, indicating a positive short-term trend, while it is slightly above the 200-day moving average of C$2.79. The stock has fluctuated between C$2.00 and C$4.25 over the past year, with its current price representing approximately 37% of that range. The trading volume has been low, with only 600 shares traded recently compared to a 20-day average of 7,966 shares, suggesting limited investor activity.
Insider Activity
No recent insider activity has been reported for TelyRx Holdings Inc., indicating a lack of significant insider buying or selling that could influence investor sentiment.
Price Action Summary
TelyRx Holdings Inc. closed at C$2.83, reflecting a 5.66% increase for the day. Despite the positive daily movement, the stock remains under pressure with a 3.45% decline over the week.
Advertisement
